Cite
Overall Health, Daily Functioning, and Quality of Life in Acute Hepatic Porphyria Patients: ENVISION, a Phase 3 Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
MLA
Eliane Sardh, et al. “Overall Health, Daily Functioning, and Quality of Life in Acute Hepatic Porphyria Patients: ENVISION, a Phase 3 Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.” Digestive and Liver Disease, vol. 52, Feb. 2020, p. e35. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4a3c86a09a54fd6ef507322b981490dd&authtype=sso&custid=ns315887.
APA
Eliane Sardh, Ulrich Stölzel, Gayle Ross, Daphne Vassiliou, Jerzy Windyga, Charles J. Parker, Amy Simon, Sioban Keel, Raili Kauppinen, Craig Penz, T. Lin, Janneke G. Langendonk, Yutaka Horie, Paolo Ventura, Penelope E. Stein, A. Sasapu, Bruce Ritchie, Bruce Wang, Aneta Ivanova, … Sushama Scalera. (2020). Overall Health, Daily Functioning, and Quality of Life in Acute Hepatic Porphyria Patients: ENVISION, a Phase 3 Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. Digestive and Liver Disease, 52, e35.
Chicago
Eliane Sardh, Ulrich Stölzel, Gayle Ross, Daphne Vassiliou, Jerzy Windyga, Charles J. Parker, Amy Simon, et al. 2020. “Overall Health, Daily Functioning, and Quality of Life in Acute Hepatic Porphyria Patients: ENVISION, a Phase 3 Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.” Digestive and Liver Disease 52 (February): e35. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4a3c86a09a54fd6ef507322b981490dd&authtype=sso&custid=ns315887.